Festina lente: Hydroxychloroquine, COVID-19 and the role of the rheumatologist

Elizabeth R. Graef; Jean W. Liew; Michael S. Putman; Julia F. Simard; Emily Sirotich; Francis Berenbaum; Alí Duarte-García; Rebecca Grainger; Carly Harrison; Maximilian F. Konig; Peter Korsten; Laurie Proulx; Dawn P. Richards; Philip C. Robinson; Sebastian E. Sattui; Manuel Francisco Ugarte-Gil; Kristen J. Young; Alfred H.J. Kim; Jeffrey A. Sparks

doi:10.1136/annrheumdis-2020-217480

Festina lente: Hydroxychloroquine, COVID-19 and the role of the rheumatologist

Elizabeth R. Graef, Jean W. Liew, Michael S. Putman, Julia F. Simard, Emily Sirotich, Francis Berenbaum, Alí Duarte-García, Rebecca Grainger, Carly Harrison, Maximilian F. Konig, Peter Korsten, Laurie Proulx, Dawn P. Richards, Philip C. Robinson, Sebastian E. Sattui, Manuel Francisco Ugarte-Gil, Kristen J. Young, Alfred H.J. Kim, Jeffrey A. Sparks

Research output: Contribution to journal › Review article › peer-review

31 Scopus citations

Original language	English
Pages (from-to)	S734-S736
Journal	Annals of the Rheumatic Diseases
Volume	79
Issue number	6
DOIs	https://doi.org/10.1136/annrheumdis-2020-217480
State	Published - 1 Jun 2020

Bibliographical note

Funding Information:
Competing interests FB reports personal fees from Boehringer, Bone Therapeutics, Expanscience, Galapagos, Gilead, GSK, Merck Sereno, MSD, Nordic, Novartis, Pfizer, Regulaxis, Roche, Sandoz, Sanofi, Servier, UCB, Peptinov, TRB Chemedica and 4P Pharma. RG reports personal fees from Pfizer, Cornerstones, Jannsen and Novartis. PK reports personal fees from GlaxoSmithKline, Sanofi-Aventis, Pfizer, Abbvie, Novartis Pharma, Eli Lilly and Bristol-Myers Squibb. AHJK reports grants from NIH (National Institutes of Health)/NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases) and Rheumatology Research Foundation and personal fees from Exagen Diagnostics and GlaxoSmithKline. JAS reports grants from NIH/NIAID (National Institute of Allergy and Infectious Diseases)/Autoimmune Centers of Excellence, the Rheumatology Research Foundation, the Brigham Research Institute and the R. Bruce and Joan M. Mickey Research Scholar Fund as well as personal fees from Bristol-Myers Squibb, Gilead, Inova, Janssen and Optum.

Keywords

antirheumatic agents
health services research
hydroxychloroquine

Access to Document

10.1136/annrheumdis-2020-217480

Cite this

Graef, E. R., Liew, J. W., Putman, M. S., Simard, J. F., Sirotich, E., Berenbaum, F., Duarte-García, A., Grainger, R., Harrison, C., Konig, M. F., Korsten, P., Proulx, L., Richards, D. P., Robinson, P. C., Sattui, S. E., Ugarte-Gil, M. F., Young, K. J., Kim, A. H. J., & Sparks, J. A. (2020). Festina lente: Hydroxychloroquine, COVID-19 and the role of the rheumatologist. Annals of the Rheumatic Diseases, 79(6), S734-S736. https://doi.org/10.1136/annrheumdis-2020-217480

@article{2553175edd0d49508d4e7261317aeae3,

title = "Festina lente: Hydroxychloroquine, COVID-19 and the role of the rheumatologist",

keywords = "antirheumatic agents, health services research, hydroxychloroquine",

author = "Graef, {Elizabeth R.} and Liew, {Jean W.} and Putman, {Michael S.} and Simard, {Julia F.} and Emily Sirotich and Francis Berenbaum and Al{\'i} Duarte-Garc{\'i}a and Rebecca Grainger and Carly Harrison and Konig, {Maximilian F.} and Peter Korsten and Laurie Proulx and Richards, {Dawn P.} and Robinson, {Philip C.} and Sattui, {Sebastian E.} and Ugarte-Gil, {Manuel Francisco} and Young, {Kristen J.} and Kim, {Alfred H.J.} and Sparks, {Jeffrey A.}",

note = "Funding Information: Competing interests FB reports personal fees from Boehringer, Bone Therapeutics, Expanscience, Galapagos, Gilead, GSK, Merck Sereno, MSD, Nordic, Novartis, Pfizer, Regulaxis, Roche, Sandoz, Sanofi, Servier, UCB, Peptinov, TRB Chemedica and 4P Pharma. RG reports personal fees from Pfizer, Cornerstones, Jannsen and Novartis. PK reports personal fees from GlaxoSmithKline, Sanofi-Aventis, Pfizer, Abbvie, Novartis Pharma, Eli Lilly and Bristol-Myers Squibb. AHJK reports grants from NIH (National Institutes of Health)/NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases) and Rheumatology Research Foundation and personal fees from Exagen Diagnostics and GlaxoSmithKline. JAS reports grants from NIH/NIAID (National Institute of Allergy and Infectious Diseases)/Autoimmune Centers of Excellence, the Rheumatology Research Foundation, the Brigham Research Institute and the R. Bruce and Joan M. Mickey Research Scholar Fund as well as personal fees from Bristol-Myers Squibb, Gilead, Inova, Janssen and Optum.",

year = "2020",

month = jun,

day = "1",

doi = "10.1136/annrheumdis-2020-217480",

language = "Ingl{\'e}s",

volume = "79",

pages = "S734--S736",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "6",

}

Graef, ER, Liew, JW, Putman, MS, Simard, JF, Sirotich, E, Berenbaum, F, Duarte-García, A, Grainger, R, Harrison, C, Konig, MF, Korsten, P, Proulx, L, Richards, DP, Robinson, PC, Sattui, SE, Ugarte-Gil, MF, Young, KJ, Kim, AHJ & Sparks, JA 2020, 'Festina lente: Hydroxychloroquine, COVID-19 and the role of the rheumatologist', Annals of the Rheumatic Diseases, vol. 79, no. 6, pp. S734-S736. https://doi.org/10.1136/annrheumdis-2020-217480

TY - JOUR

T1 - Festina lente

T2 - Hydroxychloroquine, COVID-19 and the role of the rheumatologist

AU - Graef, Elizabeth R.

AU - Liew, Jean W.

AU - Putman, Michael S.

AU - Simard, Julia F.

AU - Sirotich, Emily

AU - Berenbaum, Francis

AU - Duarte-García, Alí

AU - Grainger, Rebecca

AU - Harrison, Carly

AU - Konig, Maximilian F.

AU - Korsten, Peter

AU - Proulx, Laurie

AU - Richards, Dawn P.

AU - Robinson, Philip C.

AU - Sattui, Sebastian E.

AU - Ugarte-Gil, Manuel Francisco

AU - Young, Kristen J.

AU - Kim, Alfred H.J.

AU - Sparks, Jeffrey A.

N1 - Funding Information: Competing interests FB reports personal fees from Boehringer, Bone Therapeutics, Expanscience, Galapagos, Gilead, GSK, Merck Sereno, MSD, Nordic, Novartis, Pfizer, Regulaxis, Roche, Sandoz, Sanofi, Servier, UCB, Peptinov, TRB Chemedica and 4P Pharma. RG reports personal fees from Pfizer, Cornerstones, Jannsen and Novartis. PK reports personal fees from GlaxoSmithKline, Sanofi-Aventis, Pfizer, Abbvie, Novartis Pharma, Eli Lilly and Bristol-Myers Squibb. AHJK reports grants from NIH (National Institutes of Health)/NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases) and Rheumatology Research Foundation and personal fees from Exagen Diagnostics and GlaxoSmithKline. JAS reports grants from NIH/NIAID (National Institute of Allergy and Infectious Diseases)/Autoimmune Centers of Excellence, the Rheumatology Research Foundation, the Brigham Research Institute and the R. Bruce and Joan M. Mickey Research Scholar Fund as well as personal fees from Bristol-Myers Squibb, Gilead, Inova, Janssen and Optum.

PY - 2020/6/1

Y1 - 2020/6/1

KW - antirheumatic agents

KW - health services research

KW - hydroxychloroquine

UR - http://www.scopus.com/inward/record.url?scp=85083384822&partnerID=8YFLogxK

U2 - 10.1136/annrheumdis-2020-217480

DO - 10.1136/annrheumdis-2020-217480

M3 - Artículo de revisión

C2 - 32295786

AN - SCOPUS:85083384822

SN - 0003-4967

VL - 79

SP - S734-S736

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - 6

ER -

Festina lente: Hydroxychloroquine, COVID-19 and the role of the rheumatologist

Bibliographical note

Keywords

Access to Document

Other files and links

Cite this